Moreover, upregulation of SREBP2 in HCC tumor tissue was also observed in TCGA data (Figure 1B), and survival analysis indicated that high SREBP2 expression was correlated with poor prognosis in patients with liver cancer (Supplementary Figure S1A). The gene discussed is SREBF2; the disease is liver cancer.